By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Somatostatin and somatostatin analogs > Bynfezia pen
Somatostatin and somatostatin analogs

Bynfezia pen

https://themeditary.com/drug/bynfezia-pen-1128.html
Medically Reviewed by Judith Stewart, BPharm TheMediTary.Com | Reviewed: Jul 13, 2023  Additional Content by TheMediTary.Com

Generic name: octreotide acetate

Drug class: Somatostatin and somatostatin analogs

Dosage form: injection, for subcutaneous use 

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Mycapssa, Sandostatin, Octreotide (oral/injection), Octreotide (monograph)

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Bynfezia pen?

Bynfezia is a prescription medicine that contains octreotide, a man-made protein that is similar to a hormone in the body called somatostatin. Octreotide lowers many substances in the body such as insulin and glucagon (involved in regulating blood sugar), growth hormone, and chemicals that affect digestion.

Bynfezia is used to reduce the amount of growth hormone and insulin like growth factor 1 in adult patients with acromegaly.

Bynfezia is also used to treat flushing episodes and watery diarrhea caused by cancerous tumors (carcinoid syndrome) or tumors called vasoactive intestinal peptide tumors (VIPomas).

Warnings

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

Before taking this medicine

You should not use Bynfezia if you are allergic to octreotide.

To make sure Bynfezia is safe for you, tell your doctor if you have ever had:

  • diabetes;
  • gallbladder disease;
  • heart disease, high blood pressure, or heart rhythm disorder;
  • thyroid problems;
  • pancreatitis;
  • liver disease; or
  • kidney disease (or if you are on dialysis).

Tell your doctor if you are pregnant or breastfeeding.

Octreotide can affect certain hormones that may make it easier for you to get pregnant, even if you were unable to get pregnant before. Talk to your doctor about using birth control to avoid unwanted pregnancy.

Bynfezia is not approved for use by anyone younger than 18 years old.

Bynfezia Pen pregnancy and breastfeeding warnings (more detail)

How should I use Bynfezia pen

Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed.

Bynfezia is used to give an injection under the skin. A healthcare provider will give your first dose and may teach you how to properly use the medication by yourself.

Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you don't understand all instructions.

You will need frequent medical tests.

Store unused Bynfezia in the original carton in the refrigerator. Protect from light. Do not freeze, and throw the Bynfezia pen away if it has been frozen.

Once you begin using your Bynfezia pen, you may store it at room temperature for up to 28 days. 

Throw the Bynfezia pen away 28 days after your first use, even if there is still medicine left inside.

Use a needle only once and then place it in a puncture-proof "sharps" container. Follow state or local laws about how to dispose of this container. Keep it out of the reach of children and pets.

Detailed Bynfezia Pen dosage information
Bynfezia pen Dosage information (more detail)

Before Taking

You should not use Bynfezia if you are allergic to octreotide.

To make sure Bynfezia is safe for you, tell your doctor if you have ever had:

  • diabetes;
  • gallbladder disease;
  • heart disease, high blood pressure, or heart rhythm disorder;
  • thyroid problems;
  • pancreatitis;
  • liver disease; or
  • kidney disease (or if you are on dialysis).

Tell your doctor if you are pregnant or breastfeeding.

Octreotide can affect certain hormones that may make it easier for you to get pregnant, even if you were unable to get pregnant before. Talk to your doctor about using birth control to avoid unwanted pregnancy.

Bynfezia is not approved for use by anyone younger than 18 years old.

Bynfezia Pen pregnancy and breastfeeding warnings (more detail)

Related/similar drugs

octreotide, bromocriptine, Sandostatin, lanreotide, Somatuline Depot, Sandostatin LAR Depot

What happens if I miss a dose?

Call your doctor for instructions if you miss a dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include severe upper stomach pain, diarrhea, weight loss, warmth or tingling, numbness or cold feeling, unexplained muscle pain, weakness, weak pulse, fainting, or slow breathing (breathing may stop).

What should I avoid while using Bynfezia pen?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Bynfezia pen side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • severe constipation;
  • slow or uneven heartbeats;
  • signs of gallstones--fever, chills, nausea, vomiting, severe pain in your upper stomach spreading to your back, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
  • high blood sugar--increased thirst, increased urination, dry mouth, fruity breath odor;
  • low blood sugar--headache, hunger, sweating, irritability, dizziness, fast heart rate, and feeling anxious or shaky; or
  • underactive thyroid--extreme tired feeling, dry skin, joint pain or stiffness, muscle pain or weakness, hoarse voice, feeling more sensitive to cold temperatures, weight gain.

Common Bynfezia side effects may include:

  • gallstones;
  • nausea, vomiting, diarrhea, stomach pain, gas;
  • headache, back pain; muscle spasm; or
  • dizziness, tiredness.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Bynfezia pen Side Effects

What other drugs will affect Bynfezia pen?

Tell your doctor about all your other medicines, especially:

  • bromocriptine (Cycloset, Parlodel);
  • cyclosporine;
  • insulin or oral diabetes medicine; or
  • heart or blood pressure medication, such as beta-blockers.

This list is not complete. Other drugs may affect Bynfezia, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Tell your healthcare provider about all the medicines you take. Bynfezia may affect the way other medicines work, and other medicines may affect how Bynfezia works. If you have diabetes, your healthcare provider may change your dose of diabetes medication when you first start receiving Bynfezia or if your dose of Bynfezia is changed.

More about Bynfezia pen (Octreotide acetate)

Dosage information
Bynfezia pen Side Effects
During pregnancy
Bynfezia Prescribing Information
Drug images
Side effects
Drug class: Somatostatin and somatostatin analogs

Related treatment guides

Carcinoid Tumor
Vasoactive Intestinal Peptide Tumor
Acromegaly
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by